SCHEMBL1000429

SCHEMBL1000429

NC(=O)C1CCCN1C(=O)C(N)Cc1c[nH]cn1

nearest known ligand 0.45

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 3/20 0.44
▸ DPP8 Q6V1X1 1/20 0.44
▸ DPP9 Q86TI2 1/20 0.44
▸ TRHR P34981 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1000430 1.00 DPP4 (0.44) DPP4DPP8DPP9TRHR
SCHEMBL2182026 1.00 DPP4 (0.44) DPP4DPP8DPP9TRHR
Bromide SCHEMBL7325613 0.99 DPP4 (0.43) DPP4DPP8DPP9TRHR
Bromide SCHEMBL5735593 0.99 DPP4 (0.43) DPP4DPP8DPP9TRHR
Bromide SCHEMBL7325997 0.99 DPP4 (0.43) DPP4DPP8DPP9TRHR
SCHEMBL10454953 0.96 TRHR (0.43) DPP4DPP8DPP9TRHR
SCHEMBL10454951 0.96 TRHR (0.43) DPP4DPP8DPP9TRHR
SCHEMBL5734357 0.91 DPP4 (0.44) DPP4DPP8DPP9
SCHEMBL4595209 0.91 DPP4 (0.44) DPP4DPP8DPP9
SCHEMBL4595206 0.91 DPP4 (0.44) DPP4DPP8DPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0382842-B1 NOOTROPIC Grünenthal GmbH (DE) 1993-09-22 — — EP claimed
US-5118670-A PROCESS AND COMPOSITION FOR INCREASING BRAIN DOPAMINE RELEASE MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1992-06-02 — — US claimed
EP-0382842-A1 NOOTROPIC Grünenthal GmbH (DE) 1990-08-22 — — EP claimed
EP-0373904-A1 Process and composition for increasing brain dopamine release MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1990-06-20 — — EP claimed
EP-0194443-B1 NOVEL PEPTIDES, COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THEIR PRODUCTION TANABE SEIYAKU CO., LTD. (JP) 1989-08-30 — — EP claimed
EP-0194443-A2 Novel peptides, compositions containing them and processes for their production TANABE SEIYAKU CO., LTD. (JP) 1986-09-17 — — EP claimed
EP-0168042-A2 Dihydroorotic acid derivatives, processes for their preparing and pharmaceutical composition containing them TANABE SEIYAKU CO., LTD. (JP) 1986-01-15 — — EP claimed
US-4045556-A ANTIDEPRESSANTS, PYSCHOSTIMULANTS; SILYLATION SCHWERTNER EBERHARD 1977-08-30 — — US claimed
JP-63316724-A — — None — — JP disclosed
JP-7082166-A — — None — — JP disclosed
JP-62022797-A — — None — — JP disclosed
JP-1025728-A — — None — — JP disclosed
US-11191805-B2 Cyclic prosaposin peptides and uses thereof CHILDREN'S MEDICAL CENTER CORPORATION (US) 2021-12-07 — — US disclosed
WO-2011008005-A3 METHOD FOR PREPARING HISTIDYL-PROLINAMIDE DERIVATIVES USING A POLYMER SOLID PHASE SUPPORT 웰이앤씨 주식회사 (KR) 2011-06-23 — — WO disclosed
JP-S63316724-A ANTICONVULSANT NIPPON SHINYAKU CO LTD 1988-12-26 — — JP disclosed
US-4711878-A TREATING CENTRAL NERVOUS SYSTEM DISORDERS TANABE SEIYAKU CO., LTD. (JP) 1987-12-08 — — US disclosed
US-4665056-A CENTRAL NERVOUS SYSTEM DISORDERS TANABE SEIYAKU CO., LTD. (JP) 1987-05-12 — — US disclosed
JP-S6222797-A NOVEL PEPTIDE AND PRODUCTION THEREOF TANABE SEIYAKU CO LTD 1987-01-30 — — JP disclosed
EP-0194443-A2 Novel peptides, compositions containing them and processes for their production TANABE SEIYAKU CO., LTD. (JP) 1986-09-17 — — EP disclosed
EP-0168042-A2 Dihydroorotic acid derivatives, processes for their preparing and pharmaceutical composition containing them TANABE SEIYAKU CO., LTD. (JP) 1986-01-15 — — EP disclosed
Send feedback